Delivery Order SPE2DB22D3401-SPE2DB23FT4MC
Award Date 7/31/23
Potential Completion Date 8/1/23
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $21,030 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The firm fixed price order is for a single day of performance in Conshohocken, Pennsylvania and was awarded under an unspecified multiple award contract vehicle. DLA will provide funding for 2,000 ML of the injectable drug to support the Department of Defense's medical readiness programs. Amerisourcebergen will fulfill the order without use of major...
- The Defense Logistics Agency awarded a $24,785 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The firm fixed price order is for a single day of performance on September 15, 2023 at the contractor's facility in Conshohocken, Pennsylvania. DLA will provide funding for 2,000 units of the specified drug to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. This order was issued under DLA's...
- The Defense Logistics Agency awarded a $3,450.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 30 to August 31, 2023. The delivery order was competitively awarded utilizing...
- The Defense Logistics Agency awarded a $6,609 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 200 MG/1.14 ML SYRING 1.14ML. The firm fixed price order is being fulfilled under an existing DLA contract vehicle and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania over a one day period concluding on August 16, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the injectable drug DUPIXENT aligns with...
- The Defense Logistics Agency awarded a $44,768 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The firm fixed price order is for pharmaceutical products to be delivered to a facility in Conshohocken, Pennsylvania between August 30 and 31, 2023. Amerisourcebergen will provide the syringes as the prime contractor under an existing DLA contract vehicle. No set aside designation or subcontractors were identified. The DLA procures medical supplies and equipment...
- The Defense Logistics Agency awarded a $15,146.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Amerisourcebergen will deliver the syringes to a location in Conshohocken, Pennsylvania by September 1, 2023 to support DLA's mission to provide medical supplies and logistics...
- The Defense Logistics Agency awarded a $16,523.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 14, 2023 in support of DLA procurement programs. No set aside designation or subcontractors were identified. DLA manages the global supply chain for the Department of Defense,...
- The Defense Logistics Agency Troop Support Medical awarded a $7,711.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The delivery order, issued under an indefinite-delivery/indefinite-quantity contract vehicle, calls for Amerisourcebergen to provide 2ML syringes of the drug DUPIXENT to support the Defense Logistics Agency's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $38,004 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. Under this contract, Amerisourcebergen will provide approximately 456 units of the injectable drug to support the DLA's medical supply needs. As the prime contractor, Amerisourcebergen will perform the order itself from its facility in Conshohocken, Pennsylvania, with work expected to be completed by July 10, 2023. No subcontractors or...
- The Defense Logistics Agency awarded a $24,250 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The firm fixed price order is valued at twenty-four thousand two hundred fifty dollars and thirty-nine cents. Performance will take place in Conshohocken, Pennsylvania from August 4th through August 7th, 2023. The Defense Logistics Agency procures medical supplies and pharmaceuticals to support military treatment facilities and readiness programs. No...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB23FT4MCDelivery Order
The Defense Logistics Agency awarded a $12,254 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The firm fixed price order is for a single day of performance on August 1, 2023 at the contractor's facility in Conshohocken, Pennsylvania. DLA will provide funding for 2,000 units of the injectable drug to support the Department of Defense's medical readiness programs. No subcontractors or set aside designations were identified. Amerisourcebergen, a pharmaceutical distributor and services provider, will deliver the products from its corporate headquarters to meet DLA's stated requirements.
Generated 12/17/23, 3:32 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 7/31/23 |